Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 32NETWORK 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3

Interventions

Fluorouracil 74Leucovorin 48Oxaliplatin 44Cisplatin 40Capecitabine 39Gemcitabine 37Radiotherapy 30Irinotecan 28Cetuximab 21Paclitaxel 15Bevacizumab 12Docetaxel 10Taxes 9durvalumab 8dehydroftorafur 8Surgical Procedures, Operative 8Mitomycin 8Specimen Handling 7Platinum 7Folfox protocol 7Carboplatin 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7S 1 (combination) 6Panitumumab 6Watchful Waiting 5Imatinib Mesylate 5Gene Expression Profiling 5Epirubicin 5tremelimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Gastrectomy × Gastrointestinal × Clear all
NCT02205047 2025-07-31

INNOVATION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
172 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01924819 2025-03-04

TOPGEAR

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Active not recruiting
574 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00335959 2012-08-17

S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery

SWOG Cancer Research Network

Phase 2 Terminated
7 enrolled 7 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡